<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
<head>
    <meta charset="utf-8" />
<script>(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","https://www.google-analytics.com/analytics.js","ga");ga("create", "UA-2231938-8", {"cookieDomain":"auto"});ga("require", "linkid", "linkid.js");ga("set", "anonymizeIp", true);ga("send", "pageview");</script>
<meta name="Generator" content="Drupal 8 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Merriweather:300|Lato:italic,700|Josefin+Sans:700,300&amp;subset=latin,latin-ext" media="all" />
<link rel="shortcut icon" href="/core/misc/favicon.ico" type="image/vnd.microsoft.icon" />

        <title>Popular Pages | Insureintell.com</title>
        <link rel="stylesheet" media="all" href="/sites/site.dd/files/css/css_EM7WZGSOXJKTK2E_qJAyBfceGhIB9FIdCRBVbGwvNLg.css" />
<link rel="stylesheet" media="all" href="/sites/site.dd/files/css/css_1g_7Rhof1xPNoR5sXcW2q6l4KX3RXBNPK2sTAkysEdQ.css" />

            
<!--[if lte IE 8]>
<script src="/sites/site.dd/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script>
<![endif]-->

     <link href='//fonts.googleapis.com/css?family=Raleway:400,300,600' rel='stylesheet' type='text/css'>

                  </head>
<body class="fontyourface path-popular-">
<a href="#main-content" class="visually-hidden focusable skip-link">
    Skip to main content
</a>

  <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    
<div id="page-wrapper">
    <div id="page">
        <header id="header" class="header" role="banner" aria-label="Site header">
            <div class="section clearfix">
                
                <div class="no-mobile">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
</div>
                <nav id="navigation" class="navbar replaceme menu original">
                <div class="menu-header">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
 &nbsp; <div id="nav-icon"><span></span><span></span><span></span><span></span><span></span><span></span></div></div>
                    <div class="container">
                    
                    </div>
                </nav>
            </div>
        </header>
                    <div class="highlighted">
                <aside class="section clearfix" role="complementary">
                      <div>
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>

                </aside>
            </div>
                        <div id="main-wrapper" class=" clearfix">
            <div id="main" class="clearfix">
                
                                                    <section class="section">
                        <a id="main-content" tabindex="-1"></a>
                                                                            
                        <div class="ten">
                              <div>
    <div id="block-light-skeleton-page-title--2" class="block block-core block-page-title-block">
    
        
            <div class="content">
            
<div class="sixteen page-title container floated ">
    <h1 class="title_page" >Popular Pages</h2>
</div>


        </div>
    </div>
<section class="page-content container floated ">
<div class="views-element-container"><div class="js-view-dom-id-e1678f2468e8ad534d0071fd009153e4719f2aa69cb3ab8bd6f4a250670eee32">
  
  
  

  
  
  

      <div class="views-row">


<div data-history-node-id="25801" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/artificial-intelligence-and-future-underwriters" hreflang="en">Artificial Intelligence and the Future of Underwriters</a>
</h2>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p>After three forgettable years as a competition analyst in the agency department, I became a novice life underwriter at Northwestern Mutual on October 10, 1973.</p>

<p>The ensuing 522 months have afforded me the privilege of witnessing first hand the evolution of our profession and in so doing to marvel at the ever-accelerating pace of change.</p>

<p>Clearly, there are reasons – and reasons within reasons – why this frenetic process will intensify over the near-term future with profound implications for us, both individually and collectively.</p>

<p>The phenomenon dubbed “artificial intelligence” could (and likely will) be one of the most impactful in terms of how our profession’s future sorts out by the mid-2020s.</p>

</div>
      
            <div><h3>
  <a href="/artificial-intelligence-and-future-underwriters" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/429" property="schema:about" hreflang="en">artificial intelligence</a></div>
              <div><a href="/taxonomy/term/372" property="schema:about" hreflang="en">employment</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25799" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  The Significance of Hemoglobin A1C Levels in Nondiabetics (Munich RE)
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>It has been demonstrated that the development of microvascular complications of diabetes mellitus, especially diabetic retinopathy, can be delayed by establishing more strict glycemic control. As a result, methods of monitoring glycemic control by measuring the amount of glucose attached to various proteins in the blood have been developed.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="https://www.munichre.com/site/marclife-mobile/get/documents_E1772416219/marclife/assset.marclife/Documents/Publications/hemoglobin-WP-1-4-17.pdf" target="_blank">munichre.com</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/431" hreflang="en">Hemoglobin A1C</a></div>
              <div><a href="/taxonomy/term/115" hreflang="en">Insurance Medicine</a></div>
              <div><a href="/taxonomy/term/432" hreflang="en">nondiabetics</a></div>
              <div><a href="/taxonomy/term/114" hreflang="en">automated underwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25798" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  Medical Underwriting: The Race against Antibiotic Resistance (RGA)
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>Are Miracle Drugs Being Outmatched by Superbugs?</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="http://www.rgare.com/knowledge-center/media/articles/the-race-against-antibiotic-resistance" target="_blank">rgare.com</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/430" hreflang="en">antibiotic resistance</a></div>
              <div><a href="/taxonomy/term/63" hreflang="en">drugs</a></div>
              <div><a href="/taxonomy/term/27" hreflang="en">Medical Underwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25797" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  Middle Market Life Insurance: Findings from Industry Leaders
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>The Society of Actuaries’ Marketing and Distribution Section (MAD) announce the release of a new report on the middle-income life insurance market.  Success has been limited in this market even though over the last 10 years, a number of studies and ideas have been presented as viable strategies for serving the middle market. Authored by Doug Bennett with assistance from Stephen Camilli of ACTEX Learning, this report seeks to understand this lack of success and document the experiences of companies and distributors with significant working knowledge of the middle-income market.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="https://www.soa.org/Research/Research-Projects/Life-Insurance/middle-market-findings.aspx" target="_blank">soa.org</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/129" hreflang="en">marketing</a></div>
              <div><a href="/taxonomy/term/55" hreflang="en">middle market</a></div>
              <div><a href="/taxonomy/term/89" hreflang="en">Selling</a></div>
              <div><a href="/taxonomy/term/130" hreflang="en">simplified life insurance</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25796" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  Life Insurance Challenges Posed by Marijuana and E-cigarettes
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>An increasingly discussed area in life insurance circles is the manner in which marijuana and e-cigarettes are addressed by life insurance carriers.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="http://www.lifehealthpro.com/2017/02/13/life-insurance-challenges-posed-by-marijuana-and-e?page_all=1" target="_blank">lifehealthpro.com</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/239" hreflang="en">e-cigarettes</a></div>
              <div><a href="/taxonomy/term/64" hreflang="en">insurability</a></div>
              <div><a href="/taxonomy/term/44" hreflang="en">marijuana</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25795" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  Insurers Shouldn’t Stigmatize Epilepsy (Gen Re)
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>Epilepsy is a neurological disorder that can affect people of all ages. According to the WHO, some 50 million people around the world have epilepsy and an estimated 2.4 million new diagnoses are made each year. The condition has significant implications for life and health insurance because it is associated with loss of productivity, increased healthcare needs and even premature death.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="http://www.genre.com/knowledge/blog/insurers-shouldnt-stigmatize-epilepsy-en.html" target="_blank">genre.com</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/78" hreflang="en">epilepsy</a></div>
              <div><a href="/taxonomy/term/86" hreflang="en">Health</a></div>
              <div><a href="/taxonomy/term/64" hreflang="en">insurability</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25794" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  SCORacle UK Life Newsletter Issue 7
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>Welcome to the 7th edition of SCORacle, which contains some variation to the usual Underwriting and Claims focus and includes articles by 3 young students that spent some time with SCOR in the summer to provide their views of our industry. This provides a fascinating insight into the thoughts of our consumers of the future. In addition, we also have some interesting information from our Consultant Cardiologist on two commonly seen conditions that from an underwriting perspective we should keep an eye on and for our readers who are Claims assessors, we include some information relating to changes to death certification.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="https://www.scor.com/images/stories/pdf/library/newsletter/SCORACLE_7_Dec2016.pdf" target="_blank">scor.com</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/279" hreflang="en">cardiovascular disease</a></div>
              <div><a href="/taxonomy/term/146" hreflang="en">Claims</a></div>
              <div><a href="/taxonomy/term/48" hreflang="en">Global Industry</a></div>
              <div><a href="/taxonomy/term/56" hreflang="en">millennials</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25793" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  Medical Underwriting: UPDATED Marijuana - Not Just Blowing Smoke (RGA)
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>Legal “pot” use is no longer a pipe dream. Although marijuana remains the most commonly consumed illegal drug1 in the world, many nations and at least 28 U.S. states and the District of Columbia have decriminalized its medicinal use, and efforts to liberalize recreational consumption continue to gain momentum.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="http://www.rgare.com/knowledge-center/media/research/marijuana-not-just-blowing-smoke" target="_blank">rgare.com</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/63" hreflang="en">drugs</a></div>
              <div><a href="/taxonomy/term/44" hreflang="en">marijuana</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25792" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  Five Myths and Facts about Artificial Intelligence (SOA)
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>Artificial intelligence (AI) is splashed throughout the headlines these days. AI recently beat the human Go champion, autonomous cars can drive themselves, social bots can mimic human interactions and converse with others in social networks, and AI totally manages some hedge funds.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="https://www.soa.org/sections/pred-analytics-futurism/pred-analytics-futurism-newsletter/" target="_blank">www.soa.org</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/428" hreflang="en">AI</a></div>
              <div><a href="/taxonomy/term/429" hreflang="en">artificial intelligence</a></div>
              <div><a href="/taxonomy/term/45" hreflang="en">technology</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25791" class="node node--type-story node--view-mode-teaser ds-2col-stacked-fluid clearfix">

  

  <div class="group-header">
    
            <div><h3>
  HIV Infection: Ageing, Inflammation and Comorbidities (SCOR inFORM)
</h3>
</div>
      
            <div>Thu, 03/09/2017</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><p>From the end of the 2000s, after the introduction of the first antiretroviral therapies (ART), it became clear that the benefits of these treatments were considerably greater than their side effects, especially when introduced early. The recommendation at present is to begin treatment with ART as soon as CD4 T-cell count falls below the normal level of 500/mm3.</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="https://www.scor.com/images/stories/pdf/library/scor-inform/SCOR_in_FORM_VIH_Infla_Comorbidit_EN.pdf" target="_blank">scor.com</a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/175" hreflang="en">HIV</a></div>
              <div><a href="/taxonomy/term/326" hreflang="en">LTC</a></div>
              <div><a href="/taxonomy/term/231" hreflang="en">morbidity</a></div>
          </div>
  
  </div>

</div>

</div>

      <nav role="navigation" aria-labelledby="pagination-heading--2">
    <h4 id="pagination-heading--2" class="visually-hidden">Pagination</h4>
    <ul class="js-pager__items">
              <li>
          <a href="/popular-/page/45" title="Go to previous page" rel="prev">
            <span class="visually-hidden">Previous page</span>
            <span aria-hidden="true">‹‹</span>
          </a>
        </li>
                    <li>
          Page 46        </li>
                    <li>
          <a href="/popular-/page/47" title="Go to next page" rel="next">
            <span class="visually-hidden">Next page</span>
            <span aria-hidden="true">››</span>
          </a>
        </li>
          </ul>
  </nav>


  
  

  
  
</div>
</div>

</section>



  </div>

                        </div>
                    </section>
                                            </div>
        </div>
        <div class="clearfix"></div>
        <footer class="site-footer">
            <div class="layout-container">
                                                    <div class="site-footer__bottom container page_footer">
                          <div>
    <div id="block-foot-3" class="block block-block-content block-block-content084078bf-6f39-47ba-bdb3-8d97b34316a4">
    
        
            <div class="content">
            
            <div><footer class="text-align-center">
<h5>Insureintell.com is an independent publication designed to provide business information and opinion to life and health insurance underwriters. It is intended to encourage discussion and further research.<br />
Insureintell.com does not recommend any specific action or risk appraisal in any individual life or health insurance application. All information and opinion published should undergo formal scrutiny by underwriting officers, medical directors, actuaries, legal counsel and other insurance professionals as appropriate.</h5>

<h5>Copyright® 2019&nbsp;Hank George, Inc. All Rights Reserved.</h5>
</footer>
</div>
      
        </div>
    </div>

  </div>

                    </div>
                            </div>
        </footer>
    </div>
</div>
  </div>

<div class="region region-page-bottom"><div id="fancy_login_dim_screen"></div><div id="fancy_login_login_box"><div id="fancy_login_form_contents"><a href="#" id="fancy_login_close_button">X</a><div id="fancy_login_user_login_block_wrapper"><form class="fancy-login-user-login-form" data-drupal-selector="fancy-login-user-login-form-2" action="/popular-?page=45" method="post" id="fancy-login-user-login-form--2" accept-charset="UTF-8">
  <div class="js-form-item form-item js-form-type-textfield form-item-name js-form-item-name">
      <label for="edit-name--2" class="js-form-required form-required">Username</label>
        <input autocorrect="none" autocapitalize="none" spellcheck="false" data-drupal-selector="edit-name" type="text" id="edit-name--2" name="name" value="" size="15" maxlength="60" class="form-text required" required="required" aria-required="true" />

        </div>
<div class="js-form-item form-item js-form-type-password form-item-pass js-form-item-pass">
      <label for="edit-pass--2" class="js-form-required form-required">Password</label>
        <input data-drupal-selector="edit-pass" type="password" id="edit-pass--2" name="pass" size="15" maxlength="128" class="form-text required" required="required" aria-required="true" />

        </div>
<input autocomplete="off" data-drupal-selector="form-kzaqhpl0lnzgr-4qixrzjpqlr8g-yn4hjzejh08iuue" type="hidden" name="form_build_id" value="form-kzAQHpL0Lnzgr_4qIXrzjpQLR8G_yN4hJZejh08iuuE" />
<input data-drupal-selector="edit-fancy-login-user-login-form-2" type="hidden" name="form_id" value="fancy_login_user_login_form" />
<ul data-drupal-selector="edit-user-links"><li><a href="/user/password" title="Request new password via email.">Request new password</a></li></ul><div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions--2"><input data-drupal-selector="edit-submit-1592923530" type="submit" id="edit-submit-1592923530--2" name="op" value="Log in" class="button js-form-submit form-submit" />
</div>

</form>
</div></div></div></div>
<script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"popular-","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","currentQuery":{"page":"45"}},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"core\/drupal.ajax,core\/html5shiv,core\/jquery.form,ds\/ds_2col_stacked_fluid,extlink\/drupal.extlink,fancy_login\/popup,fontyourface\/font_display_light_skeleton,google_analytics\/google_analytics,light_skeleton\/skeleton,system\/base,views\/views.module","theme":"light_skeleton","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true,"\/popular-?page=45\u0026ajax_form=1":true},"fancyLogin":{"screenFadeColor":"grey","screenFadeZIndex":10,"loginBoxBackgroundColor":"white","loginBoxTextColor":"black","loginBoxBorderColor":"black","loginBoxBorderWidth":"1px","loginBoxBorderStyle":"solid","loginPath":"\/user\/login","dimFadeSpeed":null,"boxFadeSpeed":null,"hideObjects":false},"ajax":{"edit-submit-1592923530--2":{"callback":"fancy_login_user_login_block_ajax_callback","event":"mousedown","keypress":true,"prevent":"click","url":"\/popular-?page=45\u0026ajax_form=1","dialogType":"ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Log in"}}},"google_analytics":{"trackOutbound":true,"trackMailto":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"data":{"extlink":{"extTarget":true,"extTargetNoOverride":null,"extNofollow":null,"extFollowNoOverride":null,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":false,"extAlertText":"","mailtoClass":"0","mailtoLabel":"(link sends email)"}},"user":{"uid":0,"permissionsHash":"9eefd52671687a581488e58f9810121b71f4049b340084fc527a3c9edd844181"}}</script>
<script src="/sites/site.dd/files/js/js_e6-SH2JCxM0WNYs4R1vHEs5bWDpCzWT3qWBkLw5LK-Q.js"></script>

</body>
</html>
